Brief: Astria Therapeutics Reports First Quarter Financial Results

Astria Therapeutics

11/05/2023 21:23

May 11 (Reuters) - Astria Therapeutics Inc  ATXS.O :
    * ASTRIA THERAPEUTICS INC Q1 LOSS PER SHARE $0.40
    * ASTRIA THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL
RESULTS AND
PROVIDES A CORPORATE UPDATE
    * ASTRIA THERAPEUTICS INC Q1 EARNINGS PER SHARE VIEW $-0.55
--
REFINITIV IBES DATA
    * ASTRIA THERAPEUTICS INC - ADMINISTRATION OF STAR-0215 TO
HAE
PATIENTS IS UNDERWAY IN ALPHA-STAR PHASE 1B/2 TRIAL
    * ASTRIA THERAPEUTICS INC - ALPHA-STAR ON TRACK FOR INITIAL
PROOF-OF-CONCEPT RESULTS ANTICIPATED MID-2024
    * ASTRIA THERAPEUTICS INC - AS OF MARCH 31, 2023, CO HAD
CASH,
CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $213.3 MILLION
    * ASTRIA THERAPEUTICS INC - EXPECTS IT HAS SUFFICIENT CASH
TO FUND
CURRENT OPERATING PLAN THROUGH FIRST HALF OF 2025

Source text for Eikon:  ID:nBwlzM1na 
Further company coverage:  ATXS.O 

 ((Reuters.Briefs@thomsonreuters.com;))